(Updated - June 30, 2023 6:02 AM EDT)

Truist Securities analyst Srikripa Devarakonda initiates coverage on Kymera Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE